Replies to post #1192 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

Street expects ABBV 2nd gen to do worse than Harvoni in the most challenging population that is generating most of the scripts.

Not sure what you mean. Cirrhotic patients comprise only about 20% of the HCV patient pool.